Willow

What it is

Plans include medication, a medical evaluation, unlimited clinician access, 24/7 support and free shipping.

Offers semaglutide and tirzepatide in injectable and oral tablet forms; the site states compounded versions are not FDA-approved.

Eli Lilly sued Willow Health in April 2025 over its compounded tirzepatide marketing.

Prescribes: Compounded semaglutide and tirzepatide (injection and tablet).

What it costs

Insurance: Insurance not required; FSA/HSA eligible.

Prices change often. Check startwillow.com before you sign up.

Pros and cons

What users say

Common themes in public posts on Reddit, Trustpilot, the Better Business Bureau and app stores, summarised and linked. Individual experiences vary.

• Reddit members describe Willow's flat monthly prices (about $300-$499 depending on dose) as higher than many compounded providers, and several 2026 threads ask for cheaper places to continue or maintain.567
• Some members say Willow ships on time and its doctors answer questions, and one liked that the price included clinician check-ins.86
• Willow's compounded oral semaglutide draws scepticism; commenters say oral compounded versions are poorly absorbed, and one member reported no weight loss after 90 days and about $1,000.98
• Members followed Eli Lilly's 2025 lawsuit against Willow and welcomed reports that the court dismissed it.10
• Trustpilot reviewers like responsive support, easy signup and advance notice before refills.2
• Some reviewers saw slower results than expected, especially on pills, and found phone support lacking.2

Records we found

Official and court records we found in public sources as of October 15, 2026. This is not a live or complete record; check fda.gov, ftc.gov and court sites for the latest.

1. Feb 2026
   Court

   The U.S. District Court for the Central District of California (Judge André Birotte Jr.) granted Willow Health Services' motion to dismiss Eli Lilly's first amended complaint over compounded tirzepatide (No. 2:25-cv-03570, Feb 3, 2026).4

2. Apr 2025
   Court

   Eli Lilly sued Willow Health (with Mochi, Fella and Henry Meds) over marketing of compounded tirzepatide; allegations are unproven.3